St. Jude Children's Research Hospital launches data website for genome project

St. Jude Children's Research Hospital has launched a freely available website for published research results from the St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP). The PCGP is the largest effort to date aimed at sequencing the entire genomes of both normal and cancer cells from pediatric cancer patients, comparing differences in the DNA to identify genetic mistakes that lead to childhood cancers.

Titled "Explore," the website is designed to expand access to high-quality genomic data related to pediatric cancers, accelerate discovery and hypothesis testing, and provide comprehensive visualizations of the data. Explore is also designed to make it easier for clinical and basic researchers to search published results from the PCGP.

Launched in January 2010 in collaboration with Washington University School of Medicine in St. Louis, the PCGP is focused on sequencing the entire genomes of both normal and cancer cells from 600 childhood cancer patients in the first three years, comparing differences in the DNA to identify genetics mistakes that lead to cancer. No one had sequenced a complete prior to the PCGP, which has sequenced more than 250 sets to date. This work has already led to discoveries featured in two recent papers published in Nature reporting significant advances in understanding the genetic basis of an aggressive subtype of acute lymphoblastic leukemia (ALL), known as early T-cell precursor ALL or ETP-ALL, and in retinoblastoma.

"Explore allows researchers to access the genome project's unique, published data specific to pediatric cancers and to make discoveries of their own," said James Downing, M.D., deputy director and scientific director at St. Jude. "We want to be a catalyst for the field and accelerate progress with the research gleaned from the genome project."

Rich in visual features, Explore allows users to get an overview of the genome project's progress; access to specific diseases; summaries of current discoveries; links to associated publications; views of single-patient genome data to disease levels and more. An online workbench of sorts, Explore will also provide information on what other cancers are currently under investigation by the PCGP.

"The entire research community will now be able to mine this rich set of findings," said Clayton Naeve, Ph.D., chief information officer at St. Jude. "Access to the genome project's user-friendly data website is a step in that direction."

More information: To access Explore, go to explore.pediatriccancergenomeproject.org

Provided by St. Jude Children's Research Hospital

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

No danger of cancer through gene therapy virus

20 hours ago

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

The secret of DNA methylation

Jun 18, 2013

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

Jun 18, 2013

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

User comments

More news stories

New research shows metaphors reveal personality

(Medical Xpress)—A new study by Adam K. Fetterman, a recent doctoral graduate in psychology, and Michael D. Robinson, professor of psychology at North Dakota State University, shows that metaphors for the head and the heart ...

Empowering children in clinical trials

There is evidence that over 50 percent of medicinal products developed for children have not been tested or authorised for use by this age group. The research project RESPECT ('Relating Expectations and Needs ...